BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18235111)

  • 1. Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients.
    Gimotty PA; Guerry D; Flaherty K
    J Clin Oncol; 2008 Feb; 26(4):517-8. PubMed ID: 18235111
    [No Abstract]   [Full Text] [Related]  

  • 2. [Consensus conference. Follow-up of patients surgically treated for stage I melanoma].
    Ann Dermatol Venereol; 1995; 122(5):250-8. PubMed ID: 8572461
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vaccination therapy of melanoma].
    Schuler-Thurner B; Schuler G
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):630-45. PubMed ID: 16033483
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adjuvant and palliative therapy of melanoma. Current status].
    Tilgen W
    Chirurg; 1994 Mar; 65(3):153-63. PubMed ID: 7514966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous melanoma: detecting it earlier, weighing management options.
    Lane JE; Dalton RR; Sangueza OP
    J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894
    [No Abstract]   [Full Text] [Related]  

  • 6. [The adjuvant therapy of malignant melanoma].
    Hauschild A; Sterry W
    Dtsch Med Wochenschr; 1992 Feb; 117(8):303-6. PubMed ID: 1537268
    [No Abstract]   [Full Text] [Related]  

  • 7. Can surgeons improve survival in stage IV melanoma?
    Mosca PJ; Teicher E; Nair SP; Pockaj BA
    J Surg Oncol; 2008 Apr; 97(5):462-8. PubMed ID: 18270974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors and improving treatment of cutaneous melanoma].
    Vihinen P; Kähäri VM; Pyrhönen S
    Duodecim; 2004; 120(12):1445-56. PubMed ID: 15293705
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials.
    Korn EL; Liu PY; Lee SJ; Chapman JA; Niedzwiecki D; Suman VJ; Moon J; Sondak VK; Atkins MB; Eisenhauer EA; Parulekar W; Markovic SN; Saxman S; Kirkwood JM
    J Clin Oncol; 2008 Feb; 26(4):527-34. PubMed ID: 18235113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of survival in Japanese stage IV melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cells.
    Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S
    J Dermatol; 2008 Dec; 35(12):801-3. PubMed ID: 19239565
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for conjunctival melanoma metastasis: literature review.
    Missotten GS; de Wolff-Rouendaal D; de Keizer RJ
    Bull Soc Belge Ophtalmol; 2007; (306):23-30. PubMed ID: 18251451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy and the prognosis of malignant melanoma.
    Grin CM; Driscoll MS; Grant-Kels JM
    Semin Oncol; 1996 Dec; 23(6):734-6. PubMed ID: 8970595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for complete metastasectomy in patients with stage IV metastatic melanoma.
    Ollila DW; Gleisner AL; Hsueh EC
    J Surg Oncol; 2011 Sep; 104(4):420-4. PubMed ID: 21858837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comment on the contribution by U. Beiteke et al. Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Second comment].
    Gefeller O; Kleeberg U; Kölmel KF
    Hautarzt; 1994 Mar; 45(3):191-2; author reply 193-4. PubMed ID: 8175352
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of melanoma metastases confined to the liver and future perspectives.
    Vahrmeijer AL; van de Velde CJ; Hartgrink HH; Tollenaar RA
    Dig Surg; 2008; 25(6):467-72. PubMed ID: 19212119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rational surgical approach to the treatment of distant melanoma metastases.
    Martinez SR; Young SE
    Cancer Treat Rev; 2008 Nov; 34(7):614-20. PubMed ID: 18556133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher serum 25-hydroxy vitamin D3 levels at presentation are associated with improved survival from melanoma, but there is no evidence that later prevailing levels are protective.
    Hutchinson PE; Osborne JE; Pringle JH
    J Clin Oncol; 2010 Sep; 28(27):e492-3; author reply 494-5. PubMed ID: 20625133
    [No Abstract]   [Full Text] [Related]  

  • 20. Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis.
    Spillane AJ; Saw RP; Tucker M; Byth K; Thompson JF
    Ann Surg; 2008 Aug; 248(2):286-93. PubMed ID: 18650640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.